in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (4 weeks ago)
Join us on May 10 for another #SaferWorldbyDesign webinar and discussion: Using Transcriptomics Data in Risk Assess… https://t.co/DFTVFy3bXN
Edelweiss Connect (2 months ago)
RT @barryhardy: Semi-automated approach for generation of biological networks on drug-induced cholestasis, steatosis, hepatitis, and cirrho…
Edelweiss Connect (2 months ago)
Check out the latest #HepaRG newsletter from #SaferWorldbyDesign https://t.co/zzSZ87yOZ6 https://t.co/aGGTbhrvn5
Edelweiss Connect (2 months ago)
#SaferWorldbyDesign Internship is open! This internship program is organised by Edelweiss Connect, GmbH, and Safer… https://t.co/ZH6zFVQKQX
Edelweiss Connect (3 months ago)
#SaferWorldbyDesign Webinar: Multi-Organ-Chips in Safety and Efficacy Testing: Towards Next Generation Risk Assessm… https://t.co/tSKtONlhFo

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA